Contact
Please use this form to send email to PR contact of this press release:
Relmada Therapeutics Licenses Phase 2 Bladder Cancer Candidate, NDV-01, from Trigone Pharma, Ltd.
TO:
Please use this form to send email to PR contact of this press release:
Relmada Therapeutics Licenses Phase 2 Bladder Cancer Candidate, NDV-01, from Trigone Pharma, Ltd.
TO: